GADOLINIUM CONTAINING FULLERENES AS MRI CONTRAST AGENTS
GADOLINIUM CONTAINING FULLERENES AS MRI CONTRAST AGENTS
批准号:
6172257
负责人:
JOHN M ALFORD
金额:
$37.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-01 至 2001-12-31
中文摘要
含Gd原子的面内富勒烯是一类很有前途的新型化合物,有可能成为优异的磁共振造影剂。富勒烯是一种新发现的中空封闭壳层,所有的碳分子都可以在其壳层中容纳单个或多个稀土原子,如Gd。这类化合物在成像应用中作为造影剂具有许多重要的优点。与传统化合物不同,被捕获的稀土元素完全不受外部环境的影响,因此不会释放到体内。此外,这些化合物表现出非常高的弛豫性能,比目前的显像剂高出五倍左右。因此,它们非常适用于显像剂在体内保留较长时间的应用。该项目将改进Gd-金属富勒烯的提取和纯化方法,开发改进的使化合物可溶于水的方法,并测量由此衍生的化合物的水溶解度、松弛系数和稳定性。最好的化合物将进一步测试,以确定它们的毒性、消除途径、体内分布和半衰期,以及它们在实际MRI成像实验中的表现。拟议的商业应用:这项研究将导致开发一种全新的稀土富勒烯化合物,这些化合物不仅在提高磁共振成像的对比度方面具有潜在应用,而且在闪烁成像、PET成像和SPECT成像方面也具有潜在的应用。这类化合物还可以应用于放射性药物的输送。
英文摘要
Endohedral fullerenes containing Gd atoms are a promising new class of compounds with the potential to be superior MRI contrast agents. Fullerenes are a newly discovered class of hollow, closed shell, all carbon molecules that can hold single or multiple lanthanide atoms such as gadolinium inside their shell. Such compounds have a number of important advantages as contrast agents in imaging applications. Unlike conventional compounds, the trapped lanthanide is complete protected from the outside environment, and therefore will not be released into the body. In addition, the compounds show very high relaxivities, on the order of five times higher than current imaging agents. As a result, they are ideal in applications where the imaging agent is to be retaining in the body for a long period of time. This project will improve the methods for extracting and purifying the Gd-metallofullerenes, develop improved methods of making the compounds water soluble, and measure the water solubility, relaxivity and stability of the resulting derivitized compounds. The best compounds will be further tested to determine their toxicity, elimination pathways, in vivo distributions and half lives, and their performance in actual MRI imaging experiments. PROPOSED COMMERCIAL APPLICATIONS: This research will lead to the development of an entirely new class of lanthanide fullerene compounds that have potential applications not only in improving contrast in magnetic resonance imaging, but in scintillation imaging, PET imaging and SPECT imaging. This class of compounds could also have applications to the delivery of radio-pharmaceuticals.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Development of New Atomic-Based EPR Spin Probes
-
批准号:8253407
-
项目类别:
-
资助金额:$14.91万
-
财政年份:2012
-
负责人:JOHN M ALFORD
-
依托单位:
Lanthanide Radionuclide Production
-
批准号:7538452
-
项目类别:
-
资助金额:$17.93万
-
财政年份:2008
-
负责人:JOHN M ALFORD
-
依托单位:
Development of Improved Spin Probes for Aging Research
-
批准号:7219781
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2007
-
负责人:JOHN M ALFORD
-
依托单位:
OPTIMIZATION OF TIME-OF-FLIGHT MASS SPECTROSCOPY
-
批准号:6143975
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2000
-
负责人:JOHN M ALFORD
-
依托单位:
Development of Carboxyfullerene Drugs to Treat ALS
-
批准号:6550613
-
项目类别:
-
资助金额:$43.07万
-
财政年份:1998
-
负责人:JOHN M ALFORD
-
依托单位:
Development of Carboxyfullerene Drugs to Treat ALS
-
批准号:6666951
-
项目类别:
-
资助金额:$39.89万
-
财政年份:1998
-
负责人:JOHN M ALFORD
-
依托单位:
DEVELOPMENT OF CARBOXYFULLERENE DRUGS TO TREAT ALS
-
批准号:2715542
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1998
-
负责人:JOHN M ALFORD
-
依托单位:
CARBON ENCAPSULATED RADIONUCLIDE CHELATES
-
批准号:2011272
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:JOHN M ALFORD
-
依托单位:
GADOLINIUM CONTAINING FULLERENES AS MRI CONTRAST AGENTS
-
批准号:2776395
-
项目类别:
-
资助金额:$37.79万
-
财政年份:1996
-
负责人:JOHN M ALFORD
-
依托单位:
GADOLINIUM CONTAINING FULLERENES AS MRI CONTRAST AGENTS
-
批准号:2109715
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:JOHN M ALFORD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动
肿瘤免疫逃逸
-
批准号:2024JJ9491
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:彭罗根
-
依托单位:
三维碳纳米材料(nano-carbon@ZSM-5)的制备及应用
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张兵
-
依托单位:
理论预言的三维碳同素异构体T-carbon的制备及其物性的实验深入研究
-
批准号:52072365
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:陈广超
-
依托单位:
绿色热量运动驱动的G-Carbon系统碳生产力发展研究
-
批准号:51976085
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2019
-
负责人:傅敏
-
依托单位:
金属有机框架ZIF-67基Co@Carbon膜催化反应器设计、制备及其用于丙烷催化脱氢反应过程强化研究
-
批准号:21878100
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2018
-
负责人:黄爱生
-
依托单位:
乳腺癌发生发展过程中巨噬细胞glucose-serine-glycine-1-carbon代谢异常对肿瘤恶性进展的影响及其分子机制的研究
-
批准号:81730077
-
项目类别:重点项目
-
资助金额:290.0万元
-
批准年份:2017
-
负责人:胡海
-
依托单位:
多级g-C3N4/Carbon复合物的合成及可见光光催化研究
-
批准号:51402147
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2014
-
负责人:张林飞
-
依托单位:
黄、东海沉积物中碳黑(Black Carbon)的地球化学研究
-
批准号:40576039
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2005
-
负责人:王旭晨
-
依托单位: